{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T15:31:21Z","timestamp":1792855881958,"version":"4.5.0"},"reference-count":98,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","cidjournal.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.clindermatol.2016.05.009","type":"journal-article","created":{"date-parts":[[2016,5,22]],"date-time":"2016-05-22T09:08:28Z","timestamp":1463908108000},"page":"594-602","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Phototherapy: The vitiligo management pillar"],"prefix":"10.1016","volume":"34","author":[{"given":"Samia","family":"Esmat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wedad","family":"Mostafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rehab A.","family":"Hegazy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzan","family":"Shalaby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaneeta","family":"Sheth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randa","family":"Youssef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Medhat","family":"El-Mofty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2016.05.009_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1034\/j.1600-0781.2003.00003.x","article-title":"Photo(chemo) therapy for vitiligo","volume":"19","author":"Roelandts","year":"2003","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0010","first-page":"651","article-title":"A preliminary clinical report on the treatment of leucoderma with Ammimajus Linn","volume":"31","author":"El-Mofty","year":"1948","journal-title":"J Egypt Med Assoc"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0015","first-page":"1","article-title":"Further study on treatment of leucoderma with Ammimafuslinn","volume":"35","author":"El-Mofty","year":"1952","journal-title":"J Egypt Med Assoc"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0020","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1001\/archderm.1955.01540250016004","article-title":"Treatment of vitiligo with psoralen derivatives","volume":"71","author":"George","year":"1955","journal-title":"AMA Arch Derm"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0025","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/jid.1953.36","article-title":"Clinical and experimental studies with 8-methoxypsoralen in vitiligo","volume":"20","author":"Lerner","year":"1953","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0030","doi-asserted-by":"crossref","first-page":"78-78","DOI":"10.1016\/S0923-1811(98)00064-4","article-title":"Psoralen photobiology and photochemotherapy: 50 years of science and medicine","volume":"19","author":"Bethea","year":"1999","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0035","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1001\/archderm.1976.01630350007002","article-title":"Photochemotherapy of vitiligo. Use of orally administered psoralens and a high-intensity long-wave ultraviolet light system","volume":"112","author":"Parrish","year":"1976","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0040","first-page":"1","article-title":"PUVA-induced repigmentation of vitiligo: a histochemical (split-DOPA) and ultrastructural study","volume":"101","author":"Ortonne","year":"1979","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0045","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0190-9622(82)70159-8","article-title":"Determination of optimal topical photochemotherapy for vitiligo","volume":"7","author":"Grimes","year":"1982","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0050","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1001\/archderm.1966.01600230093025","article-title":"Hydroquinone and psoralens in the therapy of hypermelanosis and vitiligo","volume":"93","author":"Fitzpatrick","year":"1966","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0055","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1046\/j.1365-4362.1999.00654.x","article-title":"Hindiog\u02c7 lu U, Karaduman A. PUVA treatment of vitiligo: a retrospective study of Turkish patients","volume":"38","author":"Sahin","year":"1999","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0060","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1034\/j.1600-0781.2001.170403.x","article-title":"PUVA and PUVB in vitiligo\u2014are they equally effective?","volume":"17","author":"El-Mofty","year":"2001","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0065","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1600-0781.2006.00189.x","article-title":"Narrow band ultraviolet B 311 nm in the treatment of vitiligo: two right-left comparison studies","volume":"22","author":"El-Mofty","year":"2006","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0070","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1529-8019.2010.01345.x","article-title":"A large scale analytical study on efficacy of different photo(chemo) therapeutic modalities in the treatment of psoriasis, vitiligo and mycosis fungoides","volume":"23","author":"El-Mofty","year":"2010","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0075","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/1523-1747.ep12520022","article-title":"Action spectrum for phototherapy of psoriasis","volume":"76","author":"Parrish","year":"1981","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0080","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1001\/archderm.1997.03890480045006","article-title":"Treatment of vitiligo with UV-B radiation vs topical psoralen plus UV-A","volume":"133","author":"Westerhof","year":"1997","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0085","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3109\/09546634.2014.952610","article-title":"Treatment of vitiligo with NBUVB: a systematic review","volume":"26","author":"Xiao","year":"2015","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0090","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/phpp.12061","article-title":"BB-UVA vs. NBUVB in the treatment of vitiligo: a randomized controlled clinical study (single blinded)","volume":"29","author":"El-Mofty","year":"2013","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0095","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0190-9622(00)90133-6","article-title":"Treatment of generalized vitiligo in children with narrow-band (TL-01) UVB radiation therapy","volume":"42","author":"Njoo","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0100","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1365-4632.2004.02329.x","article-title":"Narrow-band UVB for the treatment of vitiligo: an emerging effective and well-tolerated therapy","volume":"44","author":"Kanwar","year":"2005","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0105","first-page":"205","article-title":"Narrow band UVB phototherapy in dermatology","volume":"70","author":"Dogra","year":"2004","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0110","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1468-3083.2006.01413.x","article-title":"Psoralen-ultraviolet A vs. narrow-band ultraviolet B phototherapy for the treatment of vitiligo","volume":"20","author":"Parsad","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0115","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1468-3083.2006.02035.x","article-title":"Comparison of systemic PUVA and NBUVB in the treatment of vitiligo: an open prospective study","volume":"21","author":"Bhatnagar","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0120","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1046\/j.1365-2230.2002.00984.x","article-title":"Psoralen photochemotherapy (PUVA) is only moderately effective in widespread vitiligo: a 10-year retrospective study","volume":"27","author":"Kwok","year":"2002","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0125","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1001\/archderm.134.5.595","article-title":"Consensus workshop on the toxic effects of long-term PUVA therapy","volume":"134","author":"Morison","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0130","doi-asserted-by":"crossref","first-page":"8456","DOI":"10.3390\/ijms14048456","article-title":"Effects of narrow band UVB (311 nm) irradiation on epidermal cells","volume":"14","author":"Reich","year":"2013","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0135","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1755-148X.2010.00703.x","article-title":"First histopathological and immunophenotypic analysis of early dynamic events in a patient with segmental vitiligo associated with halo nevi","volume":"23","author":"Van Geel","year":"2010","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0140","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1016\/j.ajpath.2011.02.016","article-title":"Systemic low-dose UVB inhibits CD8 T cells and skin inflammation by alternative and novel mechanisms","volume":"178","author":"Rana","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0145","doi-asserted-by":"crossref","first-page":"240","DOI":"10.4172\/2155-9554.1000240","article-title":"Treatment of Non-Segmental Vitiligo with Narrowband UVB Phototherapy (311 Nm): Clinical Efficacy and Mechanisms of Action","volume":"5","author":"Proshutinskaia","year":"2014","journal-title":"J Clin Exp Dermatol Res"},{"issue":"5","key":"10.1016\/j.clindermatol.2016.05.009_bb0150","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/phpp.12104","article-title":"Effect of narrow band-ultraviolet B on CD4(+) CD25(high) FoxP3(+) T-lymphocytes in the peripheral blood of vitiligo patients","volume":"30","author":"Moftah","year":"2014","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0155","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/exd.12369","article-title":"T helper 17 and Tregs: a novel proposed mechanism for NBUVB in vitiligo","volume":"23","author":"Hegazy","year":"2014","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0160","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1684\/ejd.2013.2023","article-title":"Interleukin 17, interleukin 22 and FoxP3 expression in tissue and serum of non-segmental vitiligo: a case controlled study on eighty-four patients","volume":"23","author":"Elela","year":"2013","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0165","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1177\/0300060513516294","article-title":"Role of oxidative stress in the pathogenesis of vitiligo with special emphasis on the antioxidant action of narrowband ultraviolet B phototherapy","volume":"42","author":"Karsli","year":"2014","journal-title":"J Int Med Res"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0170","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1468-3083.2011.04094.x","article-title":"Narrow-band UVB irradiation stimulates the migration and functional development of vitiligo-IgG antibodies-treated pigment cells","volume":"26","author":"Wu","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0175","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1034\/j.1600-0749.2003.00070.x","article-title":"A critical appraisal of vitiligo etiologic theories. Is melanocyte loss a melanocytorrhagy?","volume":"16","author":"Gauthier","year":"2003","journal-title":"Pigment Cell Res"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0180","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.anndiagpath.2014.01.002","article-title":"Immunohistochemical expression of aberrant Notch-1 signalling in vitiligo: an implication for pathogenesis","volume":"18","author":"Seleit","year":"2014","journal-title":"Ann Diagn Pathol"},{"issue":"565","key":"10.1016\/j.clindermatol.2016.05.009_bb0185","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/j.0906-6705.2004.00221.x","article-title":"Narrow-band ultraviolet-B stimulates proliferation and migration of cultured melanocytes","volume":"13","author":"Wu","year":"2004","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0190","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jdermsci.2014.07.005","article-title":"Effects of 1,25-dihydroxyvitamin D3 on human epidermal melanocytes and melanoblasts","volume":"76","author":"Kawakami","year":"2014","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0195","article-title":"Association of neuropeptide Y (NPY), interleukin-1B (IL1B) genetic variants and correlation of IL1B transcript levels with vitiligo susceptibility","volume":"15","author":"Laddha","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0200","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jdermsci.2012.01.012","article-title":"The effects of NB-UVB on the hair follicle-derived neural crest stem cells differentiating into melanocyte lineage in vitro","volume":"66","author":"Dong","year":"2012","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0205","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1084\/jem.189.4.711","article-title":"312-Nanometer ultraviolet B light (narrow-band UVB) induces apoptosis of T cells within psoriatic lesions","volume":"189","author":"Ozawa","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0210","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1046\/j.1365-2133.2001.04248.x","article-title":"Repigmentation of localized vitiligo with the xenon chloride laser","volume":"44","author":"Balta\u00b4s","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0215","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1046\/j.1365-4362.2003.01997.x","article-title":"308-nm excimer laser for the treatment of localized vitiligo","volume":"42","author":"Taneja","year":"2003","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0220","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1046\/j.1468-3083.2003.00818.x","article-title":"Monochromatic excimer light 308 nm in the treatment of vitiligo: a pilot study","volume":"17","author":"Leone","year":"2003","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0225","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/j.1468-3083.2007.02151.x","article-title":"Comparison between 308-nm monochromatic excimer light and narrowband UVB phototherapy (311\u2013313 nm) in the treatment of vitiligo \u2014 a multicentre controlled study","volume":"21","author":"Casacci","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0230","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1365-4632.2009.04332.x","article-title":"Clinical study of repigmentation patterns with either narrow-band ultraviolet B (NBUVB) or 308 nm excimer laser treatment in Korean vitiligo patients","volume":"49","author":"Yang","year":"2010","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0235","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3346\/jkms.2005.20.2.273","article-title":"Short-term effects of 308-nm xenon chloride excimer laser and narrow-band ultraviolet B in the treatment of vitiligo: a comparative study","volume":"20","author":"Hong","year":"2005","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0240","first-page":"188","article-title":"308-nm excimer lamp vs. 308-nm excimer laser for treating vitiligo: a randomized study","volume":"163","author":"Le Duff","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0245","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1111\/jdv.12619","article-title":"Narrowband ultraviolet B phototherapy in combination with other therapies for vitiligo: mechanisms and efficacies","volume":"28","author":"Yazdani Abyaneh","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0250","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.autrev.2014.12.003","article-title":"Why treatments do(n't) work in vitiligo: an autoinflammatory perspective","volume":"14","author":"Speeckaert","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0255","first-page":"525-257","article-title":"Efficacy and tolerability of combined treatment with NBUVB and topical tacrolimus versus NBUVB alone in patients with vitiligo vulgaris. A randomized intra-individual open comparative trial","volume":"79","author":"Satyanarayan","year":"2013","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0260","first-page":"1186","article-title":"Randomized controlled trial comparing the effectiveness of 308-nm excimer laser alone or in combination with topical hydrocortisone 17-butyrate cream in the treatment of vitiligo of the face and neck","volume":"159","author":"Sassi","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0265","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1001\/archderm.140.9.1065","article-title":"Topical tacrolimus and the 308-nm excimer laser: a synergistic combination for the treatment of vitiligo","volume":"140","author":"Passeron","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0270","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1365-2230.2010.03838.x","article-title":"Narrowband ultraviolet B as monotherapy and in combination with topical calcipotriol in the treatment of generalized vitiligo","volume":"35","author":"Gamil","year":"2010","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0275","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2174\/138945008783954970","article-title":"Cellular and molecular mechanisms involved in the action of vitamin D analogs targeting vitiligo depigmentation","volume":"9","author":"Birlea","year":"2008","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0280","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1001\/2013.jamadermatol.386","article-title":"The efficacy of afamelanotide and narrowband UV-B phototherapy for repigmentation of vitiligo","volume":"149","author":"Grimes","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0285","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1067\/mjd.2001.113475","article-title":"Oral dexamethasone pulse treatment for vitiligo","volume":"44","author":"Radakovic-Fijan","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0290","first-page":"18","article-title":"Evaluation of five different regimes for the treatment of vitiligo","volume":"55","author":"Pasricha","year":"1989","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0295","doi-asserted-by":"crossref","first-page":"357","DOI":"10.4103\/0378-6323.42905","article-title":"An open labeled, comparative clinical study on efficacy and tolerability of oral minipulse of steroid (OMP) alone, OMP with PUVA and broad\/narrow band UVB phototherapy in progressive vitiligo","volume":"74","author":"Rath","year":"2008","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0300","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1001\/archderm.1990.01670270071012","article-title":"Oral cyclosporine in the treatment of inflammatory and non inflammatory dermatoses. A clinical and immuno-pathologic analysis","volume":"126","author":"Gupta","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0305","first-page":"309","article-title":"Unstable vitiligo responding to methotrexate","volume":"64","author":"Sandra","year":"1998","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0310","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/sj.jidsp.5640189","article-title":"In vivo and in vitro evidence for hydrogen peroxide (H2 O2) accumulation in the epidermis of patients with vitiligo and its successful removal by a UVB-activated pseudocatalase","volume":"4","author":"Schallreuter","year":"1999","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0315","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1177\/0091270009335769","article-title":"Response of vitiligo to narrowband ultraviolet B and oral antioxidants","volume":"49","author":"Elgoweini","year":"2009","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0320","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1684\/ejd.2009.0699","article-title":"Comparison of the efficacy of narrow band ultraviolet B and narrow band ultraviolet B plus topical catalase-superoxide dismutase treatment in vitiligo patients","volume":"19","author":"Yuksel","year":"2009","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0325","first-page":"208","article-title":"Effect of a preceding laser dermabrasion on the outcome of combined therapy with narrowband ultraviolet B and potent topical steroids for treating nonsegmental vitiligo in resistant localizations","volume":"166","author":"Bayoumi","year":"2012","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0330","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1600-0781.2008.00385.x","article-title":"Effect of one session of ER:YAG laser ablation plus topical 5 fluorouracil on the outcome of short term NBUVB phototherapy in the treatment of non-segmental vitiligo: a left-right comparative study","author":"Anbar","year":"2008","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0335","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1755-148X.2008.00528.x","article-title":"Update on skin repigmentation therapies in vitiligo","volume":"22","author":"Falabella","year":"2009","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0340","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/dsu.12444","article-title":"A randomized controlled study of the effects of different modalities of narrow-band ultraviolet B therapy on the outcome of cultured autologous melanocytes transplantation in treating vitiligo","volume":"40","author":"Zhang","year":"2014","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0345","first-page":"1022","article-title":"Phototherapy with UV-B in vitiligo","volume":"65","author":"K\u00f6ster","year":"1990","journal-title":"Z Hautkr"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0350","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1600-0781.2006.00229.x","article-title":"Ultraviolet A in vitiligo","author":"El-Mofty","year":"2006","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0355","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/1523-1747.ep12524813","article-title":"A new apparatus with high radiation energy between 320\u2013460 nm: physical description and dermatological applications","volume":"76","author":"Mutzhas","year":"1981","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0360","doi-asserted-by":"crossref","first-page":"15","DOI":"10.5070\/D36KF6H6W8","article-title":"Association of targeted intense pulse light system UVA1-UVB and fluticasone in the treatment of vitiligo: prospective study of 10 patients","volume":"16","author":"Coelho","year":"2010","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0365","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/j.1365-4632.2011.04914.x","article-title":"The incidence of leukotrichia in segmental vitiligo: implication of poor response to medical treatment","volume":"50","author":"Lee","year":"2011","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0370","series-title":"Surgical management of vitiligo","first-page":"69","article-title":"Surgical management of vitiligo and other leukodermas: evidence-based practice guidelines","author":"Gupta","year":"2007"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0375","first-page":"1143","article-title":"Vitiligo Potential Repigmentation Index: a simple clinical score that might predict the ability of vitiligo lesions to repigment under therapy","volume":"168","author":"Benzekri","year":"2013","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0380","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1111\/j.1468-3083.2009.03233.x","article-title":"The hair follicle melanocytes in vitiligo in relation to disease duration","volume":"23","author":"Anbar","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0385","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/phpp.12029","article-title":"The effectiveness of early treatment in segmental vitiligo: retrospective study according to disease duration","volume":"29","author":"Park","year":"2013","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0390","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/j.1365-4632.2010.04609.x","article-title":"Poor response of phototherapy in segmental vitiligo with leukotrichia: role of digital microscopy","volume":"51","author":"Lee","year":"2012","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0395","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jaad.2006.09.004","article-title":"Efficacy, predictors of response, and long-term follow-up in patients with vitiligo treated with narrowband UVB phototherapy","volume":"56","author":"Nicolaidou","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0400","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/archderm.140.6.677","article-title":"Parametric modeling of narrowband UV-B phototherapy for vitiligo, using a novel quantitative tool: the vitiligo area scoring index","volume":"140","author":"Hamzavi","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0405","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1067\/S0190-9622(03)01484-1","article-title":"Narrowband ultraviolet B radiation therapy for recalcitrant vitiligo in Asians","volume":"49","author":"Natta","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0410","doi-asserted-by":"crossref","first-page":"268","DOI":"10.4103\/0378-6323.107666","article-title":"Minimal erythema dose to targeted phototherapy in vitiligo patients in Indian skin","volume":"79","author":"Sekar","year":"2013","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0415","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1001\/archderm.134.12.1532","article-title":"Nonsurgical repigmentation therapies in vitiligo. Meta-analysis of the literature","volume":"134","author":"Njoo","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0420","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1111\/j.1365-4632.2010.04694.x","article-title":"A proposal for the treatment guideline in segmental vitiligo","volume":"51","author":"Lee","year":"2012","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0425","first-page":"285","article-title":"Altered levels of Ets-1 transcription factor and matrix metalloproteinases in melanocytes from patients with vitiligo","volume":"165","author":"Kumar","year":"2011","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0430","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1600-0781.2010.00540.x","article-title":"Does topical tacrolimus ointment enhance the efficacy of narrowband ultraviolet B therapy in vitiligo? A left-right comparison study","volume":"26","author":"Majid","year":"2010","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0435","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1111\/jdv.12870","article-title":"Comorbidity profiles in association with vitiligo: a nationwide population-based study in Taiwan","volume":"29","author":"Chen","year":"2015","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0440","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1600-0781.2010.00530.x","article-title":"Recent onset vitiligo on acral areas treated with phototherapy: need of early treatment","volume":"26","author":"Lee","year":"2010","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0445","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/j.1346-8138.2005.tb00847.x","article-title":"Narrow-band UVB treatment of vitiligo in Chinese","volume":"32","author":"Chen","year":"2005","journal-title":"J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0450","doi-asserted-by":"crossref","first-page":"325","DOI":"10.4103\/0019-5154.113944","article-title":"Phototherapy in vitiligo: assessing the compliance, response and patient's perception about disease and treatment","volume":"58","author":"Kandaswamy","year":"2013","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0455","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1365-2230.2010.03969.x","article-title":"Epidermal photoprotection: comparative study of narrowband ultraviolet B minimal erythema doses with and without stratum corneum stripping in normal and vitiligo skin","volume":"36","author":"El-Khateeb","year":"2011","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0460","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1111\/j.1365-4632.2011.05454.x","article-title":"Systemic PUVA vs. narrowband UVB in the treatment of vitiligo: a randomized controlled study","volume":"51","author":"Sapam","year":"2012","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0465","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1600-0781.2006.00222.x","article-title":"Evaluation of the effects of NBUVB in both segmental and non-segmental vitiligo affecting different body sites","volume":"22","author":"Anbar","year":"2006","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0470","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1600-0781.2011.00606.x","article-title":"Photo(chemo)therapy for vitiligo","volume":"27","author":"Pacifico","year":"2011","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0475","doi-asserted-by":"crossref","first-page":"17","DOI":"10.5021\/ad.2014.26.1.17","article-title":"Spectrophotometric measurement of minimal erythema dose sites after narrowband ultraviolet B phototesting: clinical implication of spetrophotometric values in phototherapy","volume":"26","author":"Jeon","year":"2014","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0480","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1038\/sj.jid.5700417","article-title":"Photoadaptation: a path toward rational phototherapy protocols","volume":"126","author":"Hamzavi","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.009_bb0485","first-page":"1685-1619","article-title":"Vitiligo European Task Force (VETF); European Academy of Dermatology and Venereology (EADV); Union Europ\u00e9anne des M\u00e9decins Sp\u00e9cialistes (UEMS). Guidelines for the management of vitiligo: the European Dermatology Forum consensus","author":"Taieb","year":"2013","journal-title":"Arch Dermatol"},{"issue":"1","key":"10.1016\/j.clindermatol.2016.05.009_bb0490","doi-asserted-by":"crossref","first-page":"106","DOI":"10.2340\/00015555-2179","article-title":"Prediction of the occurrence of melanoma and non-melanoma skin cancer in patients with vitiligo","volume":"96","author":"Hammoud","year":"2016","journal-title":"Acta Derm Venereol"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X16301456?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X16301456?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T21:47:45Z","timestamp":1718574465000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X16301456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":98,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0738081X16301456"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2016.05.009","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phototherapy: The vitiligo management pillar","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2016.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}